0001104659-19-045979.txt : 20190814 0001104659-19-045979.hdr.sgml : 20190814 20190814192706 ACCESSION NUMBER: 0001104659-19-045979 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190813 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUFFOLO ROBERT R CENTRAL INDEX KEY: 0001187308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38630 FILM NUMBER: 191028043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614067 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320074500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 BUSINESS PHONE: (408) 385-1742 MAIL ADDRESS: STREET 1: 5941 OPTICAL COURT CITY: SAN JOSE STATE: CA ZIP: 95138 4 1 a4.xml 4 X0306 4 2019-08-13 0 0001614067 Aridis Pharmaceuticals, Inc. ARDS 0001187308 RUFFOLO ROBERT R C/O ARIDIS PHARMACUETICALS, INC. 5491 OPTICAL CT. SAN JOSE CA 95138 1 0 0 0 Stock Options 8.39 2019-08-13 4 A 0 35000 0 A 2029-08-13 Common Stock 35000 42791 D The shares underlying this stock option vest in equal monthly installments over the 36 months following the date of grant. /s/ Robert Ruffolo 2019-08-14